{
    "startDate": "2017-01-01",
    "endDate": "2017-06-30",
    "year": "2017",
    "quarter": "Q2",
    "symbol": "VKTX",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 3393651
            },
            {
                "label": "Short-term investments \u2013 available for sale",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 8689630
            },
            {
                "label": "Prepaid clinical trial costs.",
                "concept": "vktx:PrepaidClinicalTrialCosts",
                "unit": "usd",
                "value": 1732789
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 447932
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 14264002
            },
            {
                "label": "Deferred public offering and other financing costs noncurrent.",
                "concept": "vktx:DeferredPublicOfferingAndOtherFinancingCostsNoncurrent",
                "unit": "usd",
                "value": 17568
            },
            {
                "label": "Deposits",
                "concept": "DepositsAssetsNoncurrent",
                "unit": "usd",
                "value": 39341
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 14320911
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1304711
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2418355
            },
            {
                "label": "Accrued interest, current",
                "concept": "InterestPayableCurrent",
                "unit": "usd",
                "value": 59333
            },
            {
                "label": "Convertible notes payable, current (net of discount of $919,184 and $675,589 at June 30, 2017 and December 31, 2016, respectively)",
                "concept": "ConvertibleNotesPayableCurrent",
                "unit": "usd",
                "value": 3050427
            },
            {
                "label": "Debt conversion feature liability current.",
                "concept": "vktx:DebtConversionFeatureLiabilityCurrent",
                "unit": "usd",
                "value": 894152
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 7726978
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 6054
            },
            {
                "label": "Total long-term liabilities",
                "concept": "LiabilitiesNoncurrent",
                "unit": "usd",
                "value": 6054
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 7733032
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.00001 par value: 10,000,000 shares authorized at June 30, 2017 and December 31, 2016; no shares issued and outstanding at June 30, 2017 and December 31, 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.00001 par value: 300,000,000 shares authorized at June 30, 2017 and December 31, 2016; 27,697,284 and 20,823,873 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 277
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 77264402
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -70670801
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -5999
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 6587879
            },
            {
                "label": "Liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 14320911
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -10393534
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 767883
            },
            {
                "label": "Amortization of investment premiums",
                "concept": "InvestmentIncomeAmortizationOfPremium",
                "unit": "usd",
                "value": 49282
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 519960
            },
            {
                "label": "Amortization of non cash clinical trial costs.",
                "concept": "vktx:AmortizationOfNonCashClinicalTrialCosts",
                "unit": "usd",
                "value": 399587
            },
            {
                "label": "Change In Fair Value Of Debt Conversion Features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": 848374
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 743497
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -53827
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 57153
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1168957
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -7481762
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireInvestments",
                "unit": "usd",
                "value": 10426060
            },
            {
                "label": "Proceeds from sales and maturities of investments",
                "concept": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
                "unit": "usd",
                "value": 11700000
            },
            {
                "label": "Cash flows from investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 1273940
            },
            {
                "label": "Proceeds from issuances of common stock, net of underwriting discounts and commissions",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 6582278
            },
            {
                "label": "Public offering and financing costs",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 62045
            },
            {
                "label": "Value of shares withheld related to employee tax withholding",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 13871
            },
            {
                "label": "Proceeds from stock issuance under employee stock purchase plan",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 19609
            },
            {
                "label": "Cash flows from financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 6525971
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 318149
            },
            {
                "label": "Shares issued to cover future clinical trial costs",
                "concept": "StockIssued1",
                "unit": "usd",
                "value": 1800000
            },
            {
                "label": "Unpaid deferred initial public offering and financing costs.",
                "concept": "vktx:UnpaidDeferredInitialPublicOfferingAndOtherFinancingCosts",
                "unit": "usd",
                "value": 147804
            }
        ],
        "ic": [
            {
                "label": "Revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 7243529
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2707876
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 9951405
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -9951405
            },
            {
                "label": "Change In Fair Value Of Debt Conversion Features.",
                "concept": "vktx:ChangeInFairValueOfDebtConversionFeatures",
                "unit": "usd",
                "value": 848374
            },
            {
                "label": "Amortization of debt discount",
                "concept": "AmortizationOfDebtDiscountPremium",
                "unit": "usd",
                "value": 767883
            },
            {
                "label": "Amortization of financing costs equity transactions.",
                "concept": "vktx:AmortizationOfFinancingCostsEquityTransactions",
                "unit": "usd",
                "value": 519960
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": -2660
            },
            {
                "label": "Other income (expense):",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -442129
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -10393534
            },
            {
                "label": "Unrealized gain (loss) on securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 893
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -10392641
            },
            {
                "label": "Basic and diluted net loss per share",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.45
            },
            {
                "label": "Weighted-average shares used to compute basic and diluted net loss per share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 23240782
            }
        ]
    }
}